# Hopper Biotechnology

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/hopper-biotechnology

- Industry: Medical Devices & Equipment
- Headquarters: Shanghai, China
- Latest round: Angel (Aug 26, 2024)
- Investors on record: 2

## About

Established in 2022 and based in Shanghai, China, Hopper Biotechnology is a developer of 3D organ modeling and organ-on-a-chip technology for the discovery and validation of new targets in the preclinical phase of drug discovery and metabolic analysis of drug candidates. The company's founders are from Karolinska Institutet, Sweden, and China Pharmaceutical University, and one of the co-founders, Tingting Zhou, is a Master of Medical Informatics from Karolinska Institutet with more than ten years of incubation and investment experience in the biopharmaceutical field. The company has entered into partnerships with Merck, Eli Lilly and other companies. In August 2024, the company closed a round of angel funding.

The company is committed to the research and development of 3D organ models and organ-on-a-chip technology, and has developed many 3D in vitro models, including liver, intestines, blood-brain barrier, nerves, and tumors. These 3D organ models can be used in conjunction with animal testing to evaluate and validate drug safety and efficacy.

The company generates revenue by developing 3D organ modeling and organ-on-a-chip technology to provide drug companies with safety and efficacy monitoring of drugs.

The company will use the angel funding to expand its 3D organ pipeline around the needs of drug discovery and development, as well as lay out an AI-driven platform for predicting in vitro data to in vivo effects, including hepatotoxicity studies of traditional Chinese medicine.

## Funding rounds

- Angel, Aug 26, 2024 — Genesis International Equity Investment, Zhangjiang Science & Technology Venture Capital

## Investors

- Genesis International Equity Investment (https://capitalatlas.ai/funds/genesis-international-equity-investment) — Angel
- Zhangjiang Science & Technology Venture Capital (https://capitalatlas.ai/funds/zhangjiang-science-technology-venture-capital) — Angel